Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ)
CNY 8.45
(0.24%)
CNY 8.45
(0.24%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 69.89 Million CNY | -53.28% |
| 2022 | 149.59 Million CNY | 2.62% |
| 2021 | 145.77 Million CNY | 78.5% |
| 2020 | 81.66 Million CNY | -21.57% |
| 2019 | 104.12 Million CNY | 6.96% |
| 2018 | 97.35 Million CNY | 20.94% |
| 2017 | 80.49 Million CNY | 31.53% |
| 2016 | 61.2 Million CNY | 15.75% |
| 2015 | 52.87 Million CNY | 20.89% |
| 2014 | 43.73 Million CNY | 68.45% |
| 2013 | 25.96 Million CNY | 30.66% |
| 2012 | 19.87 Million CNY | 10.16% |
| 2011 | 18.03 Million CNY | -6.87% |
| 2010 | 19.36 Million CNY | 107.63% |
| 2009 | 9.32 Million CNY | -1.57% |
| 2008 | 9.47 Million CNY | -32.59% |
| 2007 | 14.06 Million CNY | 59.35% |
| 2006 | 8.82 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 77.61 Million CNY | 11.04% |
| 2024 Q3 | 92.11 Million CNY | 8.09% |
| 2024 Q2 | 85.22 Million CNY | 9.81% |
| 2023 Q1 | 156.76 Million CNY | 4.79% |
| 2023 Q4 | 69.89 Million CNY | -14.74% |
| 2023 FY | 69.89 Million CNY | -53.28% |
| 2023 Q3 | 81.97 Million CNY | 0.63% |
| 2023 Q2 | 81.46 Million CNY | -48.03% |
| 2022 FY | 149.59 Million CNY | 2.62% |
| 2022 Q4 | 149.59 Million CNY | -12.81% |
| 2022 Q3 | 171.56 Million CNY | 2.76% |
| 2022 Q2 | 166.95 Million CNY | 14.55% |
| 2022 Q1 | 145.75 Million CNY | -0.02% |
| 2021 Q4 | 145.77 Million CNY | 35.76% |
| 2021 FY | 145.77 Million CNY | 78.5% |
| 2021 Q1 | 117.19 Million CNY | 43.51% |
| 2021 Q2 | 96.6 Million CNY | -17.57% |
| 2021 Q3 | 107.38 Million CNY | 11.15% |
| 2020 Q1 | 101.41 Million CNY | -2.61% |
| 2020 Q2 | 94.55 Million CNY | -6.76% |
| 2020 FY | 81.66 Million CNY | -21.57% |
| 2020 Q4 | 81.66 Million CNY | -30.68% |
| 2020 Q3 | 117.81 Million CNY | 24.6% |
| 2019 Q4 | 104.12 Million CNY | 17.36% |
| 2019 FY | 104.12 Million CNY | 6.96% |
| 2019 Q3 | 88.72 Million CNY | -0.42% |
| 2019 Q2 | 89.1 Million CNY | -20.02% |
| 2019 Q1 | 111.4 Million CNY | 14.43% |
| 2018 Q4 | 97.35 Million CNY | 14.75% |
| 2018 Q1 | 83.55 Million CNY | 3.79% |
| 2018 Q2 | 66.77 Million CNY | -20.08% |
| 2018 Q3 | 84.84 Million CNY | 27.06% |
| 2018 FY | 97.35 Million CNY | 20.94% |
| 2017 Q2 | 60.83 Million CNY | -12.5% |
| 2017 FY | 80.49 Million CNY | 31.53% |
| 2017 Q4 | 80.49 Million CNY | 11.12% |
| 2017 Q3 | 72.44 Million CNY | 19.07% |
| 2017 Q1 | 69.53 Million CNY | 13.61% |
| 2016 FY | 61.2 Million CNY | 15.75% |
| 2016 Q2 | 44.71 Million CNY | -34.79% |
| 2016 Q4 | 61.2 Million CNY | 37.2% |
| 2016 Q3 | 44.6 Million CNY | -0.23% |
| 2016 Q1 | 68.56 Million CNY | 29.68% |
| 2015 Q2 | 53.36 Million CNY | 4.11% |
| 2015 FY | 52.87 Million CNY | 20.89% |
| 2015 Q4 | 52.87 Million CNY | -4.07% |
| 2015 Q3 | 55.11 Million CNY | 3.28% |
| 2015 Q1 | 51.25 Million CNY | 17.2% |
| 2014 Q3 | 41.02 Million CNY | 40.0% |
| 2014 FY | 43.73 Million CNY | 68.45% |
| 2014 Q1 | 21.51 Million CNY | -17.15% |
| 2014 Q2 | 29.3 Million CNY | 36.23% |
| 2014 Q4 | 43.73 Million CNY | 6.61% |
| 2013 Q3 | 27.14 Million CNY | -12.08% |
| 2013 FY | 25.96 Million CNY | 30.66% |
| 2013 Q4 | 25.96 Million CNY | -4.34% |
| 2013 Q1 | 30.16 Million CNY | 51.8% |
| 2013 Q2 | 30.87 Million CNY | 2.33% |
| 2012 Q3 | 22.52 Million CNY | 20.21% |
| 2012 Q4 | 19.87 Million CNY | -11.8% |
| 2012 FY | 19.87 Million CNY | 10.16% |
| 2012 Q1 | 17.87 Million CNY | -0.92% |
| 2012 Q2 | 18.74 Million CNY | 4.86% |
| 2011 Q4 | 18.03 Million CNY | -37.64% |
| 2011 Q2 | 19.24 Million CNY | 0.4% |
| 2011 Q1 | 19.16 Million CNY | -1.05% |
| 2011 Q3 | 28.92 Million CNY | 50.32% |
| 2011 FY | 18.03 Million CNY | -6.87% |
| 2010 Q2 | 20.23 Million CNY | -16.92% |
| 2010 Q1 | 24.35 Million CNY | 161.08% |
| 2010 FY | 19.36 Million CNY | 107.63% |
| 2010 Q4 | 19.36 Million CNY | 13.26% |
| 2010 Q3 | 17.1 Million CNY | -15.48% |
| 2009 Q4 | 9.32 Million CNY | 0.0% |
| 2009 FY | 9.32 Million CNY | -1.57% |
| 2008 FY | 9.47 Million CNY | -32.59% |
| 2007 FY | 14.06 Million CNY | 59.35% |
| 2006 FY | 8.82 Million CNY | 0.0% |